Iovance Biotherapeutics Inc
(NAS:IOVA)
$
7.99
0.04 (0.5%)
Market Cap: 2.24 Bil
Enterprise Value: 1.96 Bil
PE Ratio: 0
PB Ratio: 3.30
GF Score: 40/100 - Q4 2023 Iovance Biotherapeutics Inc Earnings Call TranscriptFeb 28, 2024$17.43 (-0.23%)Earnings
- Iovance Biotherapeutics Inc FDA Approval Call TranscriptFeb 16, 2024
- Q3 2023 Iovance Biotherapeutics Inc Earnings Call TranscriptNov 07, 2023$4.32Earnings
- Q2 2023 Iovance Biotherapeutics Inc Earnings Call TranscriptAug 08, 2023$7.14 (+1.28%)Earnings
- Iovance Biotherapeutics Inc Melanoma Treatment Landscape TranscriptJun 26, 2023
- Iovance Biotherapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Q1 2023 Iovance Biotherapeutics Inc Earnings Call TranscriptMay 09, 2023$7.36 (+3.95%)Earnings
- Iovance Biotherapeutics Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) TranscriptApr 24, 2023
- Iovance Biotherapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Iovance Biotherapeutics Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Krystal Biotech Inc, Affyimmune Therapeutics Inc, Rocket Pharmaceuticals Inc and Iovance Biotherapeutics Inc at Endpoints Webinar on Moving CGTx Clinical Development- Panel TranscriptMar 02, 2023
- Q4 2022 Iovance Biotherapeutics Inc Earnings Call TranscriptFeb 28, 2023$7.29 (+1.67%)Earnings
- Iovance Biotherapeutics Inc Corporate Call TranscriptJan 23, 2023
- Iovance Biotherapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Iovance Biotherapeutics Inc Corporate Call TranscriptNov 18, 2022
- Iovance Biotherapeutics Inc to Discuss the Pooled Analysis of Cohorts 2 and 4 of the C-144-01 Study TranscriptNov 10, 2022
- Q3 2022 Iovance Biotherapeutics Inc Earnings Call TranscriptNov 03, 2022$8.53 (-4.16%)Earnings
- Q2 2022 Iovance Biotherapeutics Inc Earnings Call TranscriptAug 04, 2022$12.54 (+4.15%)Earnings
- Iovance Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Iovance Biotherapeutics Inc at JMP Securities Life Sciences Conference TranscriptJun 15, 2022
- Iovance Biotherapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Iovance Biotherapeutics Inc to Discuss Updates for the C-144-01 Clinical Study TranscriptMay 26, 2022
- Q1 2022 Iovance Biotherapeutics Inc Earnings Call TranscriptMay 05, 2022$14.83 (-10.12%)Earnings
- Iovance Biotherapeutics Inc at Chardan Genetic Medicines and Cell Therapy Manufacturing Summit (Virtual) TranscriptApr 26, 2022
- Iovance Biotherapeutics Inc to Provide Melanoma Regulatory and Clinical Updates Call TranscriptApr 06, 2022
- Iovance Biotherapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 17, 2022
- Iovance Biotherapeutics Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 16, 2022
- Q4 2021 Iovance Biotherapeutics Inc Earnings Call TranscriptFeb 24, 2022$14.85 (+5.24%)Earnings
- Iovance Biotherapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Iovance Biotherapeutics Inc at JMP Group Hematology and Oncology Summit (Virtual) TranscriptDec 07, 2021
- Iovance Biotherapeutics Inc at Stifel Healthcare Conference (Virtual) TranscriptNov 17, 2021
- Iovance Biotherapeutics Inc at Cowen Immuno-Oncology Next Summit (Virtual) TranscriptNov 15, 2021
- Iovance Biotherapeutics Inc to Discuss SITC Clinical Data Updates TranscriptNov 13, 2021
- Q3 2021 Iovance Biotherapeutics Inc Earnings Call TranscriptNov 04, 2021$24.51 (-1.41%)Earnings
- Q2 2021 Iovance Biotherapeutics Inc Earnings Call TranscriptAug 05, 2021$23.93 (+4.96%)Earnings
- Iovance Biotherapeutics Inc to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer- Conference Call TranscriptJun 29, 2021
- Iovance Biotherapeutics Inc at JMP Securities Life Sciences Virtual Conference TranscriptJun 17, 2021
- Iovance Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Iovance Biotherapeutics Inc to Discuss Clinical Data for Lifileucel at ASCO TranscriptJun 06, 2021
- Iovance Biotherapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Q1 2021 Iovance Biotherapeutics Inc Earnings Call TranscriptMay 06, 2021$28.61 (-2.09%)Earnings
- Iovance Biotherapeutics Inc at Truist Securities Life Sciences Summit (May Series) TranscriptMay 05, 2021
- Iovance Biotherapeutics Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 17, 2021
- Iovance Biotherapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Iovance Biotherapeutics Inc at H C Wainwright Global Life Sciences Conference (Virtual)- Panel TranscriptMar 09, 2021
- Iovance Biotherapeutics Inc at H C Wainwright Global Life Sciences Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 Iovance Biotherapeutics Inc Earnings Call TranscriptFeb 25, 2021$36.51 (-7.38%)Earnings
- Iovance Biotherapeutics Inc at Guggenheim Partners Healthcare Talks Oncology Days TranscriptFeb 11, 2021
- Iovance Biotherapeutics Inc at B. Riley Oncology Investor Conference (Virtual) TranscriptJan 20, 2021
- Iovance Biotherapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Iovance Biotherapeutics Inc at Piper Sandler Healthcare Conference (Virtual)- Pre-recorded Fireside Chat TranscriptNov 20, 2020
- Iovance Biotherapeutics Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 19, 2020
- Iovance Biotherapeutics Inc at Stifel Virtual Healthcare Conference TranscriptNov 18, 2020
- Iovance Biotherapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 Iovance Biotherapeutics Inc Earnings Call TranscriptNov 05, 2020$40.42 (+2.12%)Earnings
- Iovance Biotherapeutics Inc at Jefferies Cell Therapy Summit TranscriptOct 06, 2020
- Iovance Biotherapeutics Inc Provides Update for Lifileucel in Metastatic Melanoma- Corporate Call TranscriptOct 05, 2020
- Iovance Biotherapeutics Inc at BTIG Virtual Biotechnology Conference TranscriptAug 11, 2020
- Q2 2020 Iovance Biotherapeutics Inc Earnings Call TranscriptAug 06, 2020$31.15 (+0.94%)Earnings
- Iovance Biotherapeutics Inc at JMP Securities Hematology and Oncology Forum (Virtual) TranscriptJun 18, 2020
- Iovance Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Iovance Biotherapeutics Inc Annual Shareholders Meeting TranscriptJun 08, 2020
- Iovance Biotherapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2020
- Q1 2020 Iovance Biotherapeutics Inc Earnings Call TranscriptMay 05, 2020$32.66 (+1.27%)Earnings
- Q4 2019 Iovance Biotherapeutics Inc Earnings Call TranscriptFeb 25, 2020$31.46 (+27.42%)Earnings
- Iovance Biotherapeutics Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 Iovance Biotherapeutics Inc Earnings Call TranscriptNov 04, 2019$20.46 (-6.87%)Earnings
- Q2 2019 Iovance Biotherapeutics Inc Earnings Call TranscriptAug 01, 2019$25.17 (+2.36%)Earnings
- Iovance Biotherapeutics Inc ASCO Abstracts Conference Call TranscriptMay 16, 2019
- Q1 2019 Iovance Biotherapeutics Inc Earnings Call TranscriptMay 07, 2019$11.01 (-3.93%)Earnings
- Q4 2018 Iovance Biotherapeutics Inc Earnings Call TranscriptFeb 27, 2019$10.65 (+1.91%)Earnings
Iovance Biotherapeutics Inc at BTIG Virtual Biotechnology Conference Transcript
Aug 11, 2020 / 06:30PM GMT
Release Date Price:
$28.14
(-1.37%)
Thomas Eugene Shrader
BTIG, LLC, Research Division - MD & Healthcare Analyst
Great. Thank you, Sara. So, exciting time.
Questions & Answers
Thomas Eugene Shrader
BTIG, LLC, Research Division - MD & Healthcare Analyst
Wanted to know a little bit about your thoughts on uptake. How complex is the actual TIL delivery process? Do you have a sense of which hospitals can handle this? Are they the same CAR-T hospitals? Do you have the same sort of expected side effects? Just your thoughts around the original uptake, who's going to be comfortable in the early stages?
Sara Pellegrino
Iovance Biotherapeutics, Inc. - VP of IR & Public Relations
Sure. So we are partnering now with the leading U.S. cancer centers to prepare for the launch of lifileucel. We are targeting about 40 clinical sites at launch. A lot of these sites have had experience directly with TIL as part of our clinical studies.
And as you mentioned, because CAR-T is also a more complex process that has certainly done a good job
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)